Annual SG&A
$17.08 M
+$507.00 K+3.06%
31 December 2023
Summary:
Jasper Therapeutics annual selling, general & administrative expenses is currently $17.08 million, with the most recent change of +$507.00 thousand (+3.06%) on 31 December 2023. During the last 3 years, it has risen by +$12.28 million (+255.75%). JSPR annual SG&A is now at all-time high.JSPR Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$5.43 M
+$737.00 K+15.69%
30 September 2024
Summary:
Jasper Therapeutics quarterly selling, general & administrative expenses is currently $5.43 million, with the most recent change of +$737.00 thousand (+15.69%) on 30 September 2024. Over the past year, it has increased by +$920.00 thousand (+20.38%). JSPR quarterly SG&A is now at all-time high.JSPR Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$767.39 M
-$63.53 M-9.03%
30 September 2024
Summary:
Jasper Therapeutics TTM selling, general & administrative expenses is currently -$767.39 million, with the most recent change of -$63.53 million (-9.03%) on 30 September 2024. Over the past year, it has dropped by -$785.04 million (-4447.56%). JSPR TTM SG&A is now -1984.55% below its all-time high of $18.80 million, reached on 30 September 2024.JSPR TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JSPR Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.1% | +20.4% | -4447.6% |
| 3 y3 years | +255.8% | +88.0% | -8353.3% |
| 5 y5 years | - | - | - |
JSPR Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +255.8% | at high | +88.0% | -706.0% | at low |
| 5 y | 5 years | at high | +255.8% | at high | +314.5% | -1984.5% | at low |
| alltime | all time | at high | +255.8% | at high | +314.5% | -1984.5% | at low |
Jasper Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $5.43 M(+15.7%) | $18.80 M(+5.1%) |
| June 2024 | - | $4.70 M(-1.6%) | $17.88 M(+0.9%) |
| Mar 2024 | - | $4.77 M(+22.7%) | $17.71 M(+3.7%) |
| Dec 2023 | $17.08 M(+3.1%) | $3.89 M(-13.8%) | $17.08 M(-3.3%) |
| Sept 2023 | - | $4.51 M(-0.4%) | $17.65 M(+4.9%) |
| June 2023 | - | $4.53 M(+9.4%) | $16.82 M(+4.4%) |
| Mar 2023 | - | $4.14 M(-7.2%) | $16.12 M(-2.7%) |
| Dec 2022 | $16.57 M | $4.46 M(+21.1%) | $16.57 M(+6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $3.69 M(-3.7%) | $15.53 M(+5.4%) |
| June 2022 | - | $3.83 M(-16.6%) | $14.73 M(+4.0%) |
| Mar 2022 | - | $4.59 M(+34.0%) | $14.17 M(+24.2%) |
| Dec 2021 | $11.41 M(+137.8%) | $3.42 M(+18.5%) | $11.41 M(+22.7%) |
| Sept 2021 | - | $2.89 M(-11.4%) | $9.30 M(+17.8%) |
| June 2021 | - | $3.26 M(+77.9%) | $7.89 M(+70.4%) |
| Mar 2021 | - | $1.83 M(+39.9%) | $4.63 M(+65.5%) |
| Dec 2020 | $4.80 M | $1.31 M(-11.9%) | $2.80 M(+88.1%) |
| Sept 2020 | - | $1.49 M | $1.49 M |
FAQ
- What is Jasper Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Jasper Therapeutics?
- What is Jasper Therapeutics annual SG&A year-on-year change?
- What is Jasper Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Jasper Therapeutics?
- What is Jasper Therapeutics quarterly SG&A year-on-year change?
- What is Jasper Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Jasper Therapeutics?
- What is Jasper Therapeutics TTM SG&A year-on-year change?
What is Jasper Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of JSPR is $17.08 M
What is the all time high annual SG&A for Jasper Therapeutics?
Jasper Therapeutics all-time high annual selling, general & administrative expenses is $17.08 M
What is Jasper Therapeutics annual SG&A year-on-year change?
Over the past year, JSPR annual selling, general & administrative expenses has changed by +$507.00 K (+3.06%)
What is Jasper Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of JSPR is $5.43 M
What is the all time high quarterly SG&A for Jasper Therapeutics?
Jasper Therapeutics all-time high quarterly selling, general & administrative expenses is $5.43 M
What is Jasper Therapeutics quarterly SG&A year-on-year change?
Over the past year, JSPR quarterly selling, general & administrative expenses has changed by +$920.00 K (+20.38%)
What is Jasper Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of JSPR is -$767.39 M
What is the all time high TTM SG&A for Jasper Therapeutics?
Jasper Therapeutics all-time high TTM selling, general & administrative expenses is $18.80 M
What is Jasper Therapeutics TTM SG&A year-on-year change?
Over the past year, JSPR TTM selling, general & administrative expenses has changed by -$785.04 M (-4447.56%)